• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2023 Scientific Session Call For Abstracts
      • 2023 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy-Coming Soon!
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

Klatskin Tumor in the light of ICD-O-3. A Population-Based Clinical Outcome Study Involving 1,144 Patients from the Surveillance Epidemiology and End Result (SEER) Database (2001-2012).

Abdul Waheed, MD, Jill S Motl, MD, Justin Kelly, MD, FRCS, Rebecca Rowen, MD, John R Monson, MD, FACS, FRCS, FASCRS. Surgical Health Outcomes Consortium, Florida Hospital Medical Center, Orlando, FL, USA

Introduction: Klatskin tumors (KT) occur at the confluence of right and left extrahepatic ducts and classified based on their anatomical and histological code in the International Classification of Diseases for Oncology (ICD-O). The second edition of ICD-O (ICD-O-2) allocated a distinctive histological code to KT, which was cross-referenced to the intrahepatic cholangiocarcinomas. This unclear coding may result in ambiguous reporting of the demographical and clinical features of KT. The current study aims to investigate the demographic, clinical and pathological factors impacting prognosis and survival of KT in the light of updated third edition of ICD-O (ICD-O-3).

Methods: Data on 1,144 KT patients from the Surveillance Epidemiology and End Result (SEER) database (2001-2012) was abstracted. KT patients  were analyzed for age, gender, race, stage, treatment, and long-term survival. The data was analyzed using Chi-square tests, T-tests, univariate and multivariate analysis. Kaplan- Meier analysis was used to compare long-term survival between KT and sub-groups of all biliary cholangiocarcinomas (CC).

Results: Of all biliary CC, KT comprised of 9.35 % with the mean age of diagnosis 73±13 years, was more common in males (54.8%) and Caucasians patients (69.5%). Histologically, moderately differentiated tumors were commonest (38.9%), followed by poorly differentiated (35.7%), well differentiated (23.3%) and undifferentiated tumors (2.2%), p=<0.001. Most tumors in KT group were 2-4 cm (41.5%), while fewer were >4cm (29.7%), and <2cm (28.8%), p=<0.001. ICD-O-3 defined most KT tumors in extrahepatic location (53.5%), while the remainder were in other biliary locations (46.5%), p=<0.001. Most KT patients received no treatment (73%), and those who were treated, the most frequent modality was radiation (52.7%), followed by surgery (28.1%), and both surgery and radiation (19.2%), p=<0.001. Mean survival time for KT patients treated with surgery was inferior to all CC of the biliary tree (1.72 ±2.61 vs. 1.87 ±2.18 years). P=0.047. Multivariate analysis identified regional metastasis (OR=2.8, CI=2.6-3.0), distant metastasis (OR=2.1, CI=1.9-2.4), lymph node positivity (OR=1.6, CI=1.4-1.8), Caucasian race (OR=2.0, CI=1.8-2.2), and male gender (OR=1.2, CI=1.1-1.3) to be independently associated with increased mortality for KT, p<0.001.

Conclusion: ICD-O-3 has permitted greater understanding of Klatskin tumors. This is a rare and lethal biliary malignancy that presents most often in Caucasian males in their seventh decade of life with moderately differentiated histology. Surgical resection does not provide any survival advantage compared to similarly treated biliary CC. Also, the combination of surgery and radiation appeared to provide no added survival benefits compared to other treatment modalities for KT.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 87940

Program Number: P119

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

53

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

« Return to SAGES 2018 abstract archive

Our Mission

Innovate, educate and collaborate to improve patient care.

Recently, on SAGES…

Critical View of Safety (CVS) Challenge QR Code

The SAGES Critical View of Safety Challenge – Donate Your Lap Chole Videos!

The Society of American Gastrointestinal and Endoscopic Surgeons is hosting the first Artificial Intelligence Data Challenge conducted by surgeons. The aim of this challenge is to generate a large and diverse dataset of laparoscopic cholecystectomy videos, annotated with respect to the subcomponents of the Critical View of Safety (CVS). Computer scientists from all over the […]

Respuesta de SAGES al Estudio NordICC sobre el beneficio de las colonoscopias de detección

SAGES desea aclarar los resultados del estudio NordICC y colocarlos en contexto de los esfuerzos de varias agencias nacionales para reducir el riesgo de cáncer colorrectal – la segunda causa de muerte por cáncer más frecuente en los Estados Unidos-, mediante la promoción de la detección y tratamiento oportuno de las lesiones.

SAGES Response to NordICC Study Regarding Benefit of Screening Colonoscopies

The NordICC Study recently published in The New England Journal of Medicine and widely reported on by media outlets has raised questions regarding the benefit of screening colonoscopy in lowering the risk of colorectal cancer and cancer-related deaths among otherwise healthy and symptom-free men and women aged 55 to 64. Provocative headlines and commentaries have […]

Contact SAGES

Society of American Gastrointestinal and Endoscopic Surgeons
11300 W. Olympic Blvd Suite 600
Los Angeles, CA 90064 USA
webmaster@sages.org
Tel: (310) 437-0544

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons